Mobile app alerts trained CPR bystanders to cardiac emergencies

A mobile app acquired by the Los Angeles County Fire Department sends alerts to smartphone users so cardiac arrest victims can receive lifesaving CPR from trainer bystanders, reports The Los Angeles Times.

The app, called PulsePoint, alerts mobile phone users at the same time as emergency crews to increase the odds that a cardiac arrest victim gets a lifesaving cardiopulmonary resuscitation. The program also provides CPR instruction and the location of the nearest defibrillators.

“Every person who knows CPR downloads this app and activates it has their own Fire Department radio in their pocket. They become the first responder," Franklin Pratt, MD, the L.A. County Fire Department's medical director, told the newspaper.

Once the heart stops beating, the chance for survival diminishes after about three or four minutes. If someone can perform immediate CPR to keep oxygen flowing to the brain, it can save lives.

Currently 13,000 people in L.A. County have downloaded the app, which links up with 650 emergency response systems. Registered users are able to travel between systems so they can respond to whatever incident is in their vicinity.

"The promise is to crowdsource good Samaritans," PulsePoint founder Richard Price, a former fire chief from the San Ramon Valley department in Northern California, told the Los Angeles Times.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.